These contradictory trends are reinforced by changes we see in the market access stakeholders’ map: • Payers have an increased influence on physicians’ prescriptions. They scrutinize drugs ...

“It is time to develop a joint strategy as a community, development stakeholders, quality regulators and TPHPA. After formulating this strategy we will present it to the public for review and ...